TY - JOUR
T1 - C-reactive protein-albumin ratio as a prognostic factor in renal cell carcinoma – A data from multi-institutional study in Japan
AU - Tsujino, Takuya
AU - Komura, Kazumasa
AU - Hashimoto, Takeshi
AU - Muraoka, Ryu
AU - Satake, Naoya
AU - Matsunaga, Tomohisa
AU - Tsutsumi, Takeshi
AU - Yoshikawa, Yuki
AU - Takai, Tomoaki
AU - Minami, Koichiro
AU - Uehara, Hirofumi
AU - Hirano, Hajime
AU - Nomi, Hayahito
AU - Ibuki, Naokazu
AU - Takahara, Kiyoshi
AU - Inamoto, Teruo
AU - Ohno, Yoshio
AU - Azuma, Haruhito
N1 - Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/11
Y1 - 2019/11
N2 - Introduction: The C-reactive protein to albumin ratio (CAR) has been shown to provide prognostic information in several cancers. The objective in the study is to examine the prognostic value of CAR in patients with RCC who underwent nephrectomy. Material and Methods: The record data from multi-institutional study of 1,028 patients was analyzed in the study. The cut-off value of the CAR was defined by receive operating characteristic (ROC) analysis. Overall survival (OS), cancer-specific survival (CSS), and recurrence-free survival (RFS) were evaluated, and univariate and multivariate analyses were conducted to assess the predictive value of the variables including CAR. Result: The optimal cut-off value of 0.073 in CAR was defined according to the ROC analysis. The AUC in CAR for CSS was greater than that of NLR and PLR, and that for RFS was also greater than GPS and mGPS. Multivariate analysis demonstrated that the CAR was an independent prognostic factor for OS (P < 0.001), CSS (P < 0.001) in total cohort and RFS (P = 0.029) in nonmetastatic cohort. Conclusion: The findings of the present study suggested that the preoperative CAR is an independent prognostic indicator of OS, CSS and RFS for patients with RCC. Since CAR can be assessed prior to surgery, clinicians should this take into account for the treatment decision making.
AB - Introduction: The C-reactive protein to albumin ratio (CAR) has been shown to provide prognostic information in several cancers. The objective in the study is to examine the prognostic value of CAR in patients with RCC who underwent nephrectomy. Material and Methods: The record data from multi-institutional study of 1,028 patients was analyzed in the study. The cut-off value of the CAR was defined by receive operating characteristic (ROC) analysis. Overall survival (OS), cancer-specific survival (CSS), and recurrence-free survival (RFS) were evaluated, and univariate and multivariate analyses were conducted to assess the predictive value of the variables including CAR. Result: The optimal cut-off value of 0.073 in CAR was defined according to the ROC analysis. The AUC in CAR for CSS was greater than that of NLR and PLR, and that for RFS was also greater than GPS and mGPS. Multivariate analysis demonstrated that the CAR was an independent prognostic factor for OS (P < 0.001), CSS (P < 0.001) in total cohort and RFS (P = 0.029) in nonmetastatic cohort. Conclusion: The findings of the present study suggested that the preoperative CAR is an independent prognostic indicator of OS, CSS and RFS for patients with RCC. Since CAR can be assessed prior to surgery, clinicians should this take into account for the treatment decision making.
KW - CRP/Alb ratio
KW - Inflammation-based prognostic score
KW - NLR
KW - Renal cell carcinoma
KW - Systemic inflammatory response
UR - https://www.scopus.com/pages/publications/85064861164
UR - https://www.scopus.com/pages/publications/85064861164#tab=citedBy
U2 - 10.1016/j.urolonc.2019.04.002
DO - 10.1016/j.urolonc.2019.04.002
M3 - Article
C2 - 31053528
AN - SCOPUS:85064861164
SN - 1078-1439
VL - 37
SP - 812.e1-812.e8
JO - Urologic Oncology: Seminars and Original Investigations
JF - Urologic Oncology: Seminars and Original Investigations
IS - 11
ER -
SDG 3 すべての人に健康と福祉を